Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence-based public policy making for medicines across countries: findings and implications for the future
Brian Godman, Joseph Fadare, Hye-Young Kwon, et al.
Journal of Comparative Effectiveness Research (2021) Vol. 10, Iss. 12, pp. 1019-1052
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
Tiyani Milta Sono, Eugene Vernyuy Yeika, Aislinn Cook, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 10, pp. 1025-1055
Open Access | Times Cited: 37
Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications
Linda Siachalinga, Brian Godman, Julius Chacha Mwita, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 2179-2190
Open Access | Times Cited: 26
Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
Ayukafangha Etando, Adefolarin A. Amu, Mainul Haque, et al.
Healthcare (2021) Vol. 9, Iss. 12, pp. 1722-1722
Open Access | Times Cited: 52
Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study
Kona Chowdhury, Mainul Haque, Nadia Nusrat, et al.
Antibiotics (2022) Vol. 11, Iss. 1, pp. 105-105
Open Access | Times Cited: 31
Switching Among Biosimilars: A Review of Clinical Evidence
Eleonora Allocati, Brian Godman, Marco Gobbi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Antibiotic Use and Stewardship Indicators in the First- and Second-Level Hospitals in Zambia: Findings and Implications for the Future
Aubrey Chichonyi Kalungia, Moses Mukosha, Chiluba Mwila, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1626-1626
Open Access | Times Cited: 27
A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance
Audrey Chigome, Nishana Ramdas, Phumzile Skosana, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1540-1540
Open Access | Times Cited: 14
Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications
Steward Mudenda, Robert Chilimboyi, Scott Kaba Matafwali, et al.
JAC-Antimicrobial Resistance (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications
Phumzile Skosana, Natalie Schellack, Brian Godman, et al.
Hospital Practice (2022) Vol. 50, Iss. 4, pp. 306-317
Open Access | Times Cited: 19
A Narrative Review of Recent Antibiotic Prescribing Practices in Ambulatory Care in Tanzania: Findings and Implications
Amos Massele, Anastasia Martin Rogers, Deogratias Gabriel, et al.
Medicina (2023) Vol. 59, Iss. 12, pp. 2195-2195
Open Access | Times Cited: 10
Using mystery shoppers to determine practices pertaining to antibiotic dispensing without a prescription among community pharmacies in South Africa—a pilot survey
R. Nelly Mokwele, Natalie Schellack, Elmien Bronkhorst, et al.
JAC-Antimicrobial Resistance (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 22
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
Entela Xoxi, Filippo Rumi, Panos Kanavos, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 15
Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction
D. Engler, Johanna C. Meyer, Natalie Schellack, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 996-996
Open Access | Times Cited: 17
Knowledge, attitudes and practices of healthcare professionals on the use of an electronic stock visibility and management tool in a middle-income country: Implications for access to medicines
Hlalanathi Mbonane, Mncengeli Sibanda, Brian Godman, et al.
Exploratory Research in Clinical and Social Pharmacy (2023) Vol. 9, pp. 100233-100233
Open Access | Times Cited: 6
Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
Abdul Haseeb, Zikria Saleem, Hani Faidah, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1299-1299
Open Access | Times Cited: 6
Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
Yang Hu, Zaiwei Song, Dan Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
Tao Huang, Lin Bai, Haishaerjiang Wushouer, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
The response to COVID 19 across countries and the implications for future pandemics
Mainul Haque, Marshall Gowere, Nadia Nusrat, et al.
Bangladesh Journal of Medical Science (2021), pp. 7-14
Open Access | Times Cited: 11
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
Godman Brian, Tubic Biljana, Allocati Eleonora, et al.
Journal of Applied Pharmaceutical Science (2022)
Open Access | Times Cited: 7
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
Brian Godman, Magdałene Władysiuk, Stuart McTaggart, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 8
Pharmaceutical enterprises drug quality strategy Moran analysis considering government supervision and new media participation
Yanping Xu, Lilong Zhu
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 2
Editorial: Pharmaceutical policy, impact and health outcomes
Hye-Young Kwon, Brian Godman
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Frequency and estimated costs of ten low-value practices in the Spanish primary care: a retrospective study
Kamila Cheikh‐Moussa, Johanna Caro Mendivelso, Irene Carrillo, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 7, pp. 995-1003
Closed Access | Times Cited: 4
Celebrating a Century of Insulin Discovery: A Critical Appraisal of the Emerging Alternative Insulin Delivery Systems
Ntethelelo Sibiya, Bonisiwe Mbatha, Phikelelani Ngubane, et al.
Current Drug Delivery (2022) Vol. 20, Iss. 6, pp. 656-668
Closed Access | Times Cited: 4
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland’s Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Żuber, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 557-569
Open Access
Page 1 - Next Page

Scroll to top